- Report
- February 2023
- 248 Pages
Global
From €2312EUR$2,499USD£1,944GBP
€3303EUR$3,570USD£2,777GBP
- Report
- January 2022
- 220 Pages
Global
From €2404EUR$2,598USD£2,022GBP
€3434EUR$3,712USD£2,888GBP
- Report
- April 2024
- 212 Pages
Global
From €2312EUR$2,499USD£1,944GBP
€3303EUR$3,570USD£2,777GBP
- Report
- October 2023
- 140 Pages
Global
From €2312EUR$2,499USD£1,944GBP
€3303EUR$3,570USD£2,777GBP
- Report
- April 2022
- 193 Pages
Global
From €2312EUR$2,499USD£1,944GBP
€3303EUR$3,570USD£2,777GBP
- Report
- April 2022
- 215 Pages
Global
From €2309EUR$2,496USD£1,941GBP
€3298EUR$3,565USD£2,774GBP
- Book
- July 2022
- 880 Pages
- Book
- May 2021
- 288 Pages
- Book
- September 2020
- 350 Pages

The Cardiac Valve market is a segment of the Cardiovascular Devices industry, which includes a range of products used to diagnose and treat heart conditions. Cardiac valves are used to regulate the flow of blood through the heart, and can be either mechanical or biological. Mechanical valves are typically made of metal and are designed to last for many years, while biological valves are made of animal tissue and are designed to be replaced over time. Both types of valves are used to treat a variety of heart conditions, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation.
The Cardiac Valve market is highly competitive, with a number of companies offering a range of products. Major players in the market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. Other companies in the market include CryoLife, Symetis, and Neovasc. Show Less Read more